After scientists raced to develop a Zika vaccine following the 2015 outbreak, a $110 million trial is underway. But here’s the irony: Infection rates are so low that it’s impossible to test whether the vaccine works.   It’s “a good dilemma because we don't have Zika anymore…

A Ukrainian clinic is performing pronuclear transfers for women unable to have their own children. The procedure creates embryos using DNA from 3 people and is banned by the FDA, criticized as “irresponsible human experimentation.” Experts don’t yet know if DNA changes are…

The Trump administration’s proposed new rule limiting what Title X-funded clinics can tell patients about abortion has divided secular and religious bioethicists.

Direct-to-consumer genetic testing kits like 23andMe inform buyers of their predisposition to a host of illnesses but they don’t cover assessments, next steps or even psychological support following troubling or confusing results—services traditionally provided by genetic…

Euthanasia, or ‘good death,’ is standard end-of-life care for many pets. But when it comes to humans, failing a DNR order, doctors tend to go as far as they can to save a life—but is that the best approach? asks University of California psychiatry professor Joseph Pierre.

China is leading the way in biotechnology, but its bioethics are another story, writes Yangyang Cheng. China is way ahead on using CRISPR technology to treat cancer with some 8 clinical trials. In 2006 China finally admitted to harvesting organs from executed prisoners,…